Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.19 USD | -5.56% | -11.19% | +17.82% |
05-15 | Canaccord Genuity Trims Price Target on Passage Bio to $13 From $14, Maintains Buy Rating | MT |
03-04 | Passage Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
- Stock Market
- Equities
- PASG Stock
- Charts Passage Bio, Inc.
- Static Chart